He did Master’s of Pharmacy (Pharmaceutical Technology, Formulations) from National Institute of Pharmaceutical Education and Research, Mohali and Bachelor of Pharmacy from Osmania University
In Q2 FY25, our crop protection segment reported revenue of Rs. 159 crore, with an EBIT margin of 5%
Reinforces position as first commercially approved contract development and manufacturing organization (CDMO) for ADCs in North America
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
He will join in place of Anil Arora, current President- Formulations Operations who will be superannuating in November, 2024
We now rank 3rd in pharmaceutical production by volume and 14th by value
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
Expansion includes a new 5-story, 136k sq. ft. multipurpose building in Sejong
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
Subscribe To Our Newsletter & Stay Updated